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CLINICAL/SCIENTIFIC NOTES
Peripheral synucleinopathy in a DJ1 patient with
Parkinson disease, cataracts, and hearing loss
Derek P. Narendra, MD, PhD, Risa Isonaka, PhD, Diana Nguyen, BS, Alice B. Schindler, MS, CGC,
Angela D. Kokkinis, BSN, RN, Debra Ehrlich, MD, MS, Tanya M. Bardakjian, MS, CGC,





Whereas Parkinson disease (PD) is usually sporadic, PD with onset under 50 years old can be
associated with genetic abnormalities, including rare biallelic mutations in the DJ1 gene
(PARK7).1 The DJ1 phenotype is incompletely described and has been presumed to be similar
to the Parkin (PARK2) phenotype, in which atypical clinical features are usually absent, and, in
contrast to idiopathic PD, synucleinopathy is lacking and olfaction preserved.2 Whether DJ1
patients have peripheral synucleinopathy and olfactory dysfunction has been unknown.
Methods
For immunofluorescence microscopy, 3-mm punch biopsies from the C2 area of the posterior
neck were fixed in Zamboni fixative, cryosectioned into 10-μm slices, and immunostained for
tyrosine hydroxylase (Pel-Freez Biologicals, Rogers, AR) (red), α-synuclein (Santa Cruz Bio-
technology, Santa Cruz, CA) (green), and smooth muscle actin (ACTA2; Santa Cruz Bio-
technology) (blue). Fibroblast cell lines were also established. A colocalization index for α-synuclein
and tyrosine hydroxylase was calculated from confocal images using Fiji (NIH, Bethesda, MD).
Normalized mean deviation product (nMDP) values for colocalization were tabulated from −0.1 to
+1.0, and the colocalization index calculated as log (0.1 + + nMDP [0.3–1.0]).
Standard protocol approvals, registrations, and patient consents
All participants provided written informed consent before participation in the research study,
which was approved by the National Institute of Neurological Disorders and Stroke in-
stitutional review board.
Results
We report a 35-year-old man with PD and compound heterozygous DJ1mutations. In his mid-
20s, he developed a left-hand resting tremor that progressed over years, followed by loss of
mobility, disability, and speech difficulties. His symptoms responded to levodopa, prompting
a diagnosis of PD, supported by DaT imaging (figure, A). At the time of evaluation, the patient
had resting tremor, bradykinesia, rigidity, postural instability, motor fluctuations, and dyski-
nesia. The patient’s examination was notable also for eyelid opening apraxia, hyperreflexia,
extensor plantar reflex responses bilaterally, and pseudobulbar affect (video 1). The patient was
anosmic by the University of Pennsylvania Smell Identification Test (UPSIT; score 16/40). Six
patients with early-onset PD from our clinic cohort with biallelic Parkin mutations had higher
UPSIT scores (mean 32.8; range 26–38; figure, B). In addition to his neurologic presentation,
he had sensorineural hearing loss on audiometry and visual difficulties that improved after
bilateral cataract surgery at the age of 33.
Testing for a panel of PD-related genes (Next-Generation Sequencing, Invitae, CA) revealed 2
previously unreported DJ1 variants (deletion [exon 4]; c.105dupT [p.Ala36Cysfs*12] [NM_
007262.4]). Parental testing showed these were on opposite chromosomes (figure, C). No DJ1
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protein was detectable in lysates from the patient’s fibroblasts.
Lysates from each parent had half of the normal DJ1 protein,
establishing pathogenicity of the variants (figure, D).
Immunofluorescence microscopy of skin biopsies from the
patient demonstrated substantial deposition of α-synuclein
within tyrosine hydroxylase-positive fibers. The calculated
FigurePeripheral synucleinopathy and anosmia in apatientwith early-onset Parkinsondiseasewith biallelicDJ1mutations
(A) Consecutive axial FP-CIT SPECT images demonstrate absent signal in the region of the putamen (arrows) and decreased signal in caudate heads, bilaterally
(arrowheads). (B) Clinical characteristics of the DJ1 patient and 6 biallelic Parkin patients for whomUniversity of Pennsylvania Smell Identification Test (UPSIT)
data were available. (C) Pedigree of DJ1 family. Filled in symbol indicates affected individual. (D) fibroblast lysates from a control adult dermal fibroblast line
(ATCC), the affected patient, and his unaffected parents were separated on sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) gels and
immunoblotted for DJ1 (MBL International, Woburn, MA). (E, F) Representative confocal images (F) and quantification (E) of α-synuclein (green) within
sympathetic noradrenergic nerve fibers (red) innervating dermal piloerector muscles (blue). Normal range is based on measurements from 4 healthy
controls and 7 patients with multiple system atrophy.3 Scale bar = 20 μm. AAO = age at onset; H&Y = Hoehn & Yahr; LEDD = levodopa equivalent daily dose;
UPDRS = Unified Parkinson’s Disease Rating Scale.
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colocalization index, 2.0, was above the control range in our
series (−1.0 to 1.3, n = 11; figure, E and F); and within the
range of idiopathic PD (0.9–4.9, n = 9).3
Discussion
We identified novel compound heterozygous DJ1 mutations
in a patient with early-onset PD. A prior report of a DJ1 case
noted postmortem Lewy body pathology in the brain.4 Here
we report deposition of α-synuclein in sympathetic norad-
renergic nerves in biopsied skin from a living patient. To-
gether these reports support the view that DJ1/PARK7
involves synucleinopathy within both the brain and the
sympathetic nervous system. We also provide evidence that
olfaction can be severely compromised in DJ1/PARK7. Data
on peripheral synucleinopathy and olfaction, key phenotypic
features that distinguish most patients with Parkin from
patients with idiopathic PD,2 were previously missing for
DJ1/PARK7 on review of the 32 reported cases (appendix e-1:
doi.org/10.5061/dryad.nv892mp). These findings suggest
that the DJ1 phenotype resembles that of idiopathic PD more
closely than that of Parkin/PARK2 PD.
This case and review of the literature also underscore atypical
features of theDJ1/PARK7 clinical phenotype. Early cataracts
were present in 3 cases (9.1%), 2 of whom also had sensorineural
hearing loss (6.1%).5,6 The triad of early-onset PD, cataracts, and
sensorineural hearing loss may be specific forDJ1/PARK7, as we
are unaware of their co-occurrence in other PD cases. Recent
studies suggest that DJ1 is a deglycase, repairing cellular damage
from reactive aldehydes and protecting against oxidative damage.
Reactive aldehydes and oxidative damage are implicated in cat-
aractogenesis, pointing to a possible mechanism for premature
cataract development in DJ1/PARK7.7
We expand the DJ1 phenotype to include autonomic synu-
cleinopathy and impaired olfaction, distinguishing it from the
Parkin/PARK2 phenotype. In addition, we suggest that the
clinical triad of early-onset PD, cataracts, and sensorineural
hearing loss may be specific for DJ1/PARK7.
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